| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Co-chief Executive Officer | Chief Executive Officer | Director +2 more
3 companies
Meckler Jeffrey A is a Chief Executive Officer at Cocrystal Pharma, Inc. with holdings across 3 companies. Recent SEC Form 4 filings include 11 buys and 1 sell.
Estimated insider holdings value: $5.1M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2024 | TVTX Travere Therapeutics, Inc. | Director | Sale+OE | 40,000 | $14.06 | $562,324.00 | -33.1% | +23.8% | +70.8% | |
| Nov 21, 2022 | INDP Indaptus Therapeutics, Inc. | CEO And Director | Buy | 10,000 | $1.89 | $18,945.48 | +7.6% | -2.8% | +15.5% | |
| Sep 8, 2022 | INDP Indaptus Therapeutics, Inc. | CEO And Director | Buy | 10,308 | $2.80 | $28,862.40 | +18.7% | -25.1% | +16.3% | |
| Sep 7, 2022 | INDP Indaptus Therapeutics, Inc. | CEO And Director | Buy | 9,692 | $2.56 | $24,770.64 | +10.6% | -30.0% | +20.6% | |
| Jun 6, 2022 | INDP Indaptus Therapeutics, Inc. | CEO And Director | Buy | 19,727 | $2.63 | $51,882.01 | +76.9% | -7.2% | -30.2% | |
| Nov 18, 2021 | INDP Indaptus Therapeutics, Inc. | CEO And Director | Buy | 11,187 | $5.82 | $65,108.34 | +77.4% | -7.5% | -67.6% | |
| Sep 14, 2021 | INDP Indaptus Therapeutics, Inc. | CEO And Director | Buy | 12,000 | $7.00 | $84,000.00 | +487.8% | -10.6% | -63.2% | |
| Mar 15, 2016 | COCP Cocrystal Pharma, Inc. | Chief Executive Officer | Buy | 294,118 | $0.51 | $150,000.18 | +81.0% | - | - | |
| Mar 4, 2016 | TVTX Travere Therapeutics, Inc. | Director | Buy | 5,000 | $15.31 | $76,564.50 | +10.6% | - | - | |
| Mar 3, 2016 | TVTX Travere Therapeutics, Inc. | Director | Buy | 10,000 | $14.45 | $144,500.00 | +27.0% | - | - |